SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives
Vascular Biology · 09.02.2021 · 3 (1) · R15-R23
DOI: 10.1530/vb-20-0017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vascular Biology, erschienen am 09.02.2021. Verfasst von Roberta Giordo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, Un…. Die Arbeit wurde bisher 45-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
SARS-CoV-2 is the agent responsible for the coronavirus disease (COVID-19), which has been declared a pandemic by the World Health Organization. The clinical evolution of COVID-19 ranges from asymptomatic infection to death. Older people and patients with underlying medical conditions, particularly diabetes, cardiovascular and chronic respiratory diseases are more susceptible to develop severe forms of COVID-19. Significant endothelial damage has been reported in COVID-19 and growing evidence supports the key pathophysiological role of this alteration in the onset and the progression of the disease. In particular, the impaired vascular homeostasis secondary to the structural and functional damage of the endothelium and its main component, the endothelial cells, contributes to the systemic proinflammatory state and the multiorgan involvement observed in COVID-19 patients. This review summarizes the current evidence supporting the proposition that the endothelium is a key target of SARS-CoV-2, with a focus on the molecular mechanisms involved in the interaction between SARS-CoV-2 and endothelial cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
- Department of Medical, Surgical and Experimental Surgery, University of Sassari, Sassari, Italy.
- Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Adelaide, Australia.
- Department of Biomedical Sciences, University of Sassari, Viale San Pietro, Sassari, Italy.
ORCID-Profile: Gianfranco Pintus
Zitieren
APA
Giordo, R., Paliogiannis, P., Mangoni, A. A., & Pintus, G. (2021). SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vascular Biology, 3(1), R15-R23. https://doi.org/10.1530/vb-20-0017
Vancouver
Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vascular Biology. 2021;3(1):R15-R23. doi:10.1530/vb-20-0017
BibTeX
@article{Giordo2021,
author = {Giordo, Roberta and Paliogiannis, Panagiotis and Mangoni, Arduino Aleksander and Pintus, Gianfranco},
title = {SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives},
journal = {Vascular Biology},
year = {2021},
volume = {3},
number = {1},
pages = {R15--R23},
doi = {10.1530/vb-20-0017}
}
EUVIMED